Captopril PDF

Preview

Summary

ATI Active Learning Medication Template for Captopril...

Description

ACTIVE LEARNING TEMPLATE:

Medication

Merrill STUDENT NAME Kassandra _____________________________________ (Capoten) MEDICATION captopril __________________________________________________________________________

REVIEW MODULE CHAPTER ___________

CATEGORY CLASS Antihypertensive ______________________________________________________________________

PURPOSE OF MEDICATION

Expected Pharmacological Action

Therapeutic Use

Reduces peripheral arterial resistance in hypertensive patients

Reduction in BP

Complications

Medication Administration

Fever

Angioedema

Hypotension

Hyperkalemia

Nephrotic syndrome

Hyponatremia

Adults to adolescents:Take one hour before meals Initial: 25 mg bid. or tid. Increased to 50 mg b.i.d. or t.i.d. after 1-2 wk Range: 25 mg bid or tid- 450 mg/day

Contraindications/Precautions Combination therapy with a neeprilysin inhibitor or within 36 hrs of switching to or from sacubitril/valsartan; concurrent aliskiren use in patients w/diabetes or patients w/renal impairment Precautions: Hypertension, Heart failure, Hyperkalemia

Nursing Interventions Monitor closely patient's BP Monitor renal function tests fot signs of nephrotic syndrome

Interactions

Monitor WBC regularly

ACE inhibitors: Increased risk of hypotension, hyperkalemia, & renal impairment cyclosporine: Increased risk of hyperkalemia diuretics: Additive hypotensive effects Activities: alcohol use: Additive hyptoensive effects Food: moderate to high potassium-containing foods: Possibly increased risk of hyperkalemia

Evaluation of Medication Effectiveness Reduction of peripheral arterial resistance in hypertensive patients Increase in renal blood flow Reductions of blood pressure

ACTIVE LEARNING TEMPLATES

Client Education Instruct patient to take captopril 1 hr a.c.; Tell patient to rise slowly from sitting or lying to minimize orthostatic hypotension; Avoid sunlight or wear sunscreen; Warn patient not to stop taking drug abruptly; Urge patient not to use salt substitues that contain potassium; Urge patient to tell prescriber about signs and symptoms of infection; Advise female patient of childbearing age, to notify prescriber immediately if pregnancy occurs

THERAPEUTIC PROCEDURE

A7...